SLXNW Silexion Therapeutics Corp: institutional ownership and insider trading
23 funds reported holding $144K of Silexion Therapeutics Corp in their latest 13F filings; in Q2 2026 funds net bought $2.47K, with 1 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $31.0K on the open market.
SLXNW revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$3.55M, EPS 5.17
- Quarter ended Mar 31, 2026: revenue n/a, net income −$2.73M, EPS 8.46
- Quarter ended Dec 31, 2025: revenue n/a, net income −$4.41M, EPS 5.15
- Quarter ended Sep 30, 2025: revenue n/a, net income −$3.26M, EPS 2.88
Famous investors holding SLXNW
- Izzy Englander (Millennium Management): $380, 0.0% of the portfolio
Largest institutional holders of SLXNW
- DeepCurrents Investment Group LLC — $36.2K
- Oasis Management Co Ltd. — $28.3K
- Polar Asset Management Partners Inc. — $20.8K
- LINDEN ADVISORS LP — $9.48K
- CLEAR STREET LLC — $8.99K
- ARISTEIA CAPITAL, L.L.C. — $6.64K
- Clear Street Group Inc. — $6.63K
- SECURITY BENEFIT LIFE INSURANCE CO /KS/ — $4.56K
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $3.80K
- Kepos Capital LP — $3.00K
Recent SLXNW insider trades
- Mar 26, 2026: Shirvan Mitchell sold 22,818 shares ($31.0K)
5%+ owners
- Moringa Sponsor, LP: 17.7% (Schedule 13D/A, filed Sep 28, 2026)
- Moringa Partners Ltd: 14.7% (Schedule 13D/A, filed Sep 23, 2025)
- Lincoln Alternative Strategies LLC: 6.2% (Schedule 13G, filed Sep 15, 2025)